Sun Pharmaceutical Industries Ltd. (SUNPHARMA.NS), Thursday announced clinical efficacy and safety data of Leqselvi for the treatment of adults with severe alopecia areata, an autoimmune disease.
The findings, presented at the 33rd European Academy of Dermatology and Venereology Congress, revealed that the FDA-approved treatment improved hair satisfaction scores, and anxiety and depression in the candidates.
Currently, Sun Pharma's stock is trading at INR 1,898.40, up 1.49 percent on the National Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.